Condition: Postoperative Pain · Sponsor: Pacira Pharmaceuticals, Inc
This Phase 1, multicenter, open-label, randomized, bupivacaine-controlled study is designed to evaluate the pharmacokinetics (PK) and safety of EXPAREL vs. bupivacaine HCl for postsurgical analgesia in pediatric subjects aged 0 to less than 6 years of age undergoing cardiac surgery, utilizing local infiltration analgesia (LIA).
This description comes directly from the study's public registry record.
Sarah Shaffer · 973-451-4071 · sarah.shaffer@pacira.com
Always discuss trial participation with your own doctor first.
| Indiana University Health, Riley Hospital For Children | Indianapolis, Indiana, United States | Recruiting |
| St. Louis Children's Hospital (SLCH) | St Louis, Missouri, United States | Recruiting |
| Duke University Health System | Durham, North Carolina, United States | Recruiting |
| University of Oklahoma (OU) - Medical Center - The Children's Hospital | Oklahoma City, Oklahoma, United States | Recruiting |
| The University of Texas Health Science Center at Houston (UTHSC-H) - McGovern Medical School | Houston, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06271265